Lymphocytic Population and Vitamin D

Abe J. Moriya Y. Seito M. Sugawara V. Suda T. Nishii Y. , 1986. Modulation of cell growth, differentiation, and production of interleukin-3 by 1,25-dihydroxyvitamin D3 in the murine myelocytic leukemia cell line WEHI-3. Cancer Res., 46: 6316–6321.

Amento E. P. Kurnick J. T. Krane S. M. , 1985. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. J. Immunol., 134, 1: 350–357.

Baker P. E. Fahey J. V. Munck A. , 1981, Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cell. Immunol., 61: 52–61.

Baran D. T. Milne M. L. , 1986. 1,25-dihydroxyvitamin D increases hepatocyte cytosolic calcium levels; a potential regulator of vitamin-D-hydroxylase. J. Clin. Invest., 77. 05: 1622–1626.

Bell N. H. , 1985. Vitamin D-endocrine system. J. Clin. Invest, 76: 1–6.

Bhalla A. K. Amanto E. P. Serog B. Glimcher L. H. , 1984. 1,25-dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol., 133, 4: 1748–1754.

Bhalla A. K. Amento E. P. Krane S. M. , 1986. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol., 98: 311–322.

Bhalla A. K. Amento E. P. Clemens T. L. Holick M. F. Krane S. M. , 1983. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrin. Metab., 57, 6: 1308–1310.

Bonnard G. D. Yasaka K. Jacobson D. , 1979. Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cells. J. Immunol., 123, 6: 2704–2708.

Cavaillon J.-M. Haeffner-Cavaillon N. , 1986. L'interleukine 1: Un mediateur aux multiples functions. Presse Med., 15, 5: 185–187.

De Boland A. R. De Boland R. L. , 1987. Rapid changes in skeletal muscle calcium uptake induced in vitro by 1,25-hydroxyvitamin D3 are suppressed by calcium channel blockers. Endocrinol., 210, 5: 1858–1864.

Dinarello C. A. Mier J. W. , 1987. Lymphokines. N. Eng. J. Med., 317, 15: 940–945.

Dodd R. C. Winkler C. F. Williams M. E. Bunn P. A. Gray T. K. , 1986. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch. Intern. Med., 146: 1971–1972.

Dukovich M. Wano Y. Bich-Thuy L. Katz P. Cullen B. R. Kehrl J. H. Greene W. C. , 1987. Identification of a second human interleukin-2 binding protein and its role in the assembly of the high affinity IL-2 receptor. Nature (Lond.), 327: 518–522.

Editorial. 1987. Vitamin D: New perspectives. The Lancet, i, 1122–1123.

Eriksen E. F. Nielsen H. K. Mosekilde L. Nielsen N. B. Melsen F. , 1986. Nuclear uptake of 1,25-dihydroxy-H3-cholecalciferol in peripheral blood monocytes. Scand. J. Immunol., 24: 171–177.

Espevik T. 1985. 1,25-dihydroxyvitamin D3-differentiated human promyelocy tic leukemia cells HL-60 can kill antibody-coated tumor cells K562. Scand. J. Immunol., 22: 105–109.

Fetchick D. A. Bertolini D. R. Sarin P. S. Weintraub S. T. Mundy G. R. Dunn J. F. , 1986. Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotropic Virus- I-transformed lymphocytes. J. Clin. Invest., 78: 592–596.

Garabedian M. 1983. Le metabolisme de la vitamin D. Chap., 1: 1–20, in Vitamin D et maladies des os et du metabolisme mineral. Fournier A. Garabedian M. Sebert J.-L. Meunier P.-J. , Ed. Masson.

Gillis S. Crabtree G. R. Smith K. A. , 1979. Glucocorticoid-induced inhibition of T cell growth factor production. The effect on mitogen-induced lymphocyte proliferation. J. Immunol., 123, 4: 1624–1631.

Gray T. K. Cohen M. S. , 1985. Vitamin D, phagocyte differentiation and immune function. Surv. immunol. Res., 4: 200–212.

Haq A. U. 1986. 1,25-dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus, 8: 295–306.

Haverty T. Haddad J. G. Neilson E. G. , 1987. 1,25-dihydroxyvitamin D3 stimulates interleukin-2 production by a T cell lymphoma line (MLA-144) cultured in vitamin D-deficient rat serum. J. Leuk. Biol., 41: 177–182.

Helikson M. A. Havey A. D. Zerwekh J. E. Breslau N. A. Gardner D. W. , 1986. Plasma-cell granuloma producing calcitriol and hypercalcemia. Ann. Int. Med., 105: 379–381.

Holdler B. Evequoz V. Trechsel U. Fleisch H. Stadler B. , 1985. Influence of vitamin D3 metabolites on the production of interleukins 1, 2 and 3. Immunobiol., 170: 256–269.

Hoshino T. Iho S. Kura F. , 1986. Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells. Meth. Find. Exptl. Clin. Pharmacol., 8. 3: 167–173.

Iho S. Takayuki T. Kura F. Sugiyama H. Hoshino T. , 1986. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J. Immunol., 136, 12: 4427–4431.

Iho S. Kura F. Sugiyama H. Takahashi T. Hoshino T. , 1985. The role of monocytes in the suppression of PHA-induced proliferation and IL2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3. Immunol. Letter, 11: 331–336.

Koeffler H. P. Reichel H. Bishop J. E. Norman A. W. , 1985. Gamma interferon stimulates production of 1,25-dihydroxyvitamin D₃ by normal human macrophages. Bioch. Biophys. Res. Comm., 127, 2: 596–603.

Koizumi T. Nakao Y. Matsui T. Nakagawa T. Katakami Y. Fujita T. , 1985. Effect of 1,25-dihydroxyvitamin D3 on cytokine-induced thymocyte proliferation. Cell. Immunol., 96: 455–461.

Komoriya K. Nagata I. Tsuchimoto M. Kunisawa K. Takeshita T. Naruchi T. , 1985. 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 supress in vitro antibody response to T cell-dependent antigen. Bioch. Biophys. Res. Comm., 127, 3: 753–758.

Koren R. Ravid A. Rotem C. Shohami E. Liberman U. A. Novogrodsky A. , 1986. 1,25-dihydroxyvitamin D3 enhances prostaglandin E₂ production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)₂ D₃ on lymphocytes. FEBS, 205, 1: 113–116.

Koren R. Ravid A. Liberman U. A. Hochberg Z. Weisman Y. Novogrodsky A. , 1985. Defective binding and function of 1,25-dihydroxyvitamin D receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin. D. J. Clin. Invest., 76: 2012–2015.

Kunkel S. L. Chensue S. W. Phan S. H. , 1986. Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol., 136, 1: 186–192.

Lacey D. L. Axelrod J. Chappel J. C. Kahn J. A. Teitelbaum S. L. , 1987. Vitamin D affects proliferation of a murine T helper cell clone. J. Immunol., 138, 6: 1680–1686.

Lemire J. M. Adams J. S. Sakai R. Jordan S. C. , 1984. 1,25-dihydroxyvitamin D supresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest., 74: 657–661.

Lemire J. M. Adams J. S. Kermani-Arab V. Bakke A. C. Sakai R. Jordan S. C. , 1985. 1,25-dihydroxyvitamin D suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol., 134, 5: 3032–3035.

Lipkowitz S. Greene W. C. Rubin A. L. Novogrodsky A. Stenzel K. H. , 1984. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J. Immunol., 132, 1: 31–37.

Lorente F. Fontan G. Jara P. Casas C. Ojeda J. A. Garcia-Rodriguez M. C. , 1976. Defective neutrophil motility in hypovitaminosis D rickets. Acta Paediat. Scand., 65: 695–699.

Malek T. R. Ashwell J. D. , 1985. Interleukin 2 upregulates expression of its receptor on a T cell clone. J. Exp. Med., 161: 1575–1580.

Manolagas S. C. Provvedini D. M. Murray E. J. Tsoukas C. D. Deftos L. J. , 1986. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J. Clin. Endocrin. Metab., 63, 2: 394–400.

Manolagas S. C. Provvedini D. M. Tsoukas C. D. , 1985. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol. Cell. Endocrin., 43: 113–122.

Manolagas S. C. Deftos L. J. , 1984. The vitamin D endocrine system and the hematolymphopoietic tissue. Ann. Intern. Med., 100, 1: 144–146.

Matsui T. Takayashi R. Nakao Y. Koizumi T. Katakami Y. Mihara K. Sugiyama T. Fujita T. , 1986. 1,25-dihydroxyvitamin D₃-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res., 46: 5827–5831.

Matsui T. Nakao Y Koizumi T. Nakagawa T. Fujita T. , 1985. 1,25-dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets. Life Science, 37, 1: 95–101.

McCarthy D. Hibbin J. San Miguel J. F. Freake H. Rodrigues B. Andrews C. Pinching A. , 1984. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro. Intern. J. Cell Cloning, 2: 227–242.

Mizel S. B. , 1982. Interleukin 1 and T cell activation. Immunol. Rev., 63: 51–72.

Motel P. A. Manolagas S. C. S. C. Provvedini D. M. Wegmann D. R. Chiller J. M. , 1986. Interfero-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D₃. J. Immunol., 136, 6: 2181–2186.

Mudde A. H. Van den Berg H. Boshuis P. G. Breedveld F. C. Markusse H. M. Kluin P. M. Bijvoet O. L. M. , 1987. Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer, 59, 9: 1543–1546.

Nakao Y. Koizumi T. Matsui T. Matsuda S. Takagawa T. Katakami Y. Fujita T. Maeda S. 1987. Effect of 1,25-dihydroxyvitamin D₃ on proliferation of activated T-cells and established human lymphotropic virus type I-positive T-cell lines. J.N.C.I., 78, 6: 1079–1086.

Neckers L. M. Cossman J. , 1983. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc. Natl. Acad. Sci USA, 80: 3494–3498.

Norman A. M. , 1985. The vitamin D endocrine system. The Physiologist, 284: 219–232.

Nunn J. D. Katz D. R. Barker S. Fraher L. J. Hewison M. Hendy G. N. O'Riordan J. L. H. , 1986. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology, 59: 479–484.

Pike J. W. , 1985. Intracellular receptors mediate the biologic action of 1,25-dihydroxyvitamin D₃. Nutr. Rev., 43, 6, 161–168.

Polla B. S. Healy A. M. Wojno W. C. Krane S. M. , 1987. Hormone 1,25-dihydroxyvitamin D3 modulates heat shock response monocytes. Am. J. Physiol. 252: 640–649

Polli N. Brien M. O. de Castro J. Tavares Rodrigues B. McCarthy D. Catovsky D . 1985. Monocytic differentiation induced by 1,25-dihydroxyvitamin D3 in myeloid cells: An ultrastructural immunocytochemical study. Leuk. Res., 9. 2: 259–270.

Provyedini D. M. Tsoukas C. D. Deftos L. J. Manolagas S. C. , 1986. 1,25-dihydroxyvitamin D₃-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J. Immunol., 136, 8: 2734–2740.

Provyedini D. M. Deftos L. J. Manolagas S. C. , 1984. 1,25-dihydroxyvitamin D₃ receptors in a subset of mitotically active lymphocytes from rat thymus. Bioch. Biophys. Res. Comm., 121, 1: 277–283.

Provvedini D. M. Tsoukas C. D. Deftos L. J. Manolagas S. C. , 1983. 1,25-dihydroxyvitamin D₃ receptors in human leukocytes. Science, 221: 1181–1183.

Provyedini D. M. Rulot C. M. Sobol R. E. Tsoukas C. D. Manolagas S. C. , 1987. 1,25-dihydroxyvitamin D₃ receptors in human thymic and tonsillar lymphocytes. J. Bone Miner. Res., 2, 3: 239–247.

Rappaport R. S. Dodge G. R. , 1982. Prostaglandin E inhibits the production of human interleukin 2. J. Exp. Med., 155: 943–948.

Ravid A. Koren R. Novogrodsky A. Liberman U. A. , 1984. 1,25-dihydroxyvitamin D₃ inhibits selectively the mitogenic stimulation of mouse medullary thymocytes. Biochem. Biophys. Res. Comm., 123, 1: 163–169.

Reem G. H. Yeh N. H. , 1984. Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. Science, 225: 429–430.

Reichel H. Koeffler H. P. Norman A. W. , 1987. 25-hydroxyvitamin D₃ metabolism by human T-lymphotropic virus-transformed lymphocytes. J. Clin. Endocrin. Metab., 65, 3: 519–526.

Reichel H. Koeffler H. P. Barbers R. Norman A. W. , 1987. Regulation of 1,25-dihydroxyvitamin D₃ production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J. Clin. Endocr. Metab., 65, 6: 1201–1209.

Reinhardt T. A. Hustmyer F. G. , 1987. Role of vitamin D in the immune system. J. Dairy Sci., 70: 952–962.

Reinhardt T. A. Horst R. L. Littledike E. T. Beitz D. C. , 1982. 1,25-dihydroxyvitamin D₃ receptor in bovine thymus gland. Bioch. Biophys. Res. Comm., 106, 3: 1012–1018.

Rigby W. F. C. Shen L. Ball E. D. Guyre P. M. Fanger M. W. , 1984. Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D₃ (calcitriol): A morphologic, phenotypic, and functional analysis. Blood, 64, 5: 1110–1115.

Rigby W. F. C. Denome S. Fanger M. W. , 1987. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D₃. Specific inhibition at the level of messenger RNA. J. Clin. Invest., 79: 1659–1664.

Rigby W. F. C. Noelle R. J. Krause K. Fanger M. W. , 1985. The effects of 1,25-dihydroxyvitamin D₃ on human T lymphocyte activation and proliferation: A cell cycle analysis. J. Immunol., 135, 4: 2279–2286.

Rigby W. F. C. Stacy T. Fanger M. W. , 1984. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D₃ (calcitriol). J. Clin. Invest., 74: 1451–1455.

Rook G. A. W. , 1985. Gamma interferon and calcitriol formation by human macrophages. Bioessays, 5, 1:40.

Rosenthal N. Insogna K. L. Godsall J. W. Smaldone L. Waldron J. A. Stewart A. F. , 1985. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J. Clin. Endocrin. Metab., 60, 1: 29–33.

Shiozawa K. Shiozawa S. Shimizu S. Fujita T. , 1985. 1,25-dihydroxyvitamin D₃ inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions. Immunology, 56: 161–167.

Smith K. A. Cantrell D. A. , 1985. Interleukin 2 regulates its own receptors. Proc. Natl. Acad. Sci. USA, 82: 864–868.

Stroeder J. Kasal P. , 1970. Evaluation of phagocytosis in rickets. Acta Paediat. Scand., 59: 288–292.

Thomas G. A. Simpson R. U. , 1986. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D₃ receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration. Cancer Biochem. Biophys., 8: 221–234.

Tobler A. Reichel G. H. Norman A. W. Koeffler H. P. , 1987. Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J. Clin. Invest., 79: 1700–1705.

Tsoukas C. D. Provvedini D. M. Manolagas S. C. , 1984. 1,25-dihydroxyvitamin D3: A novel immunoregulatory hormone. Science, 224: 1438–1440.

Walker C. Kristensen F. Bettens F. de Wech A. L. , 1983. Lymphokine regulation of activated (G1) lymphocytes. Prostaglandin E₂-induced inhibition of interleukin 2 production. J. Immunol., 130, 4: 1770–1773.

Weinberg J. B. Misukonis M. A. Hobbs M. M. Borowitz M. J. , 1986. Cooperative effects of gamma interferon and 1,25-dihydroxyvitamin D₃ in inducing differentiation of human promyelocytic leukemia HL-60 cells. Exp. Hematol., 14: 138–142.

Weiss A. Imboden J. Shoback D. Stobo J. D. , 1984. Role of T3 surface molecules in human T cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA, 81: 4169–4173.

Weiss M. J. Daley J. F. Hodgdon J. C. Reinherz E. C. , 1984. Calcium dependency of antigen-specific (T3-Ti) and alternative (T11) patways of human T cell activation. Proc. Natl. Acad. Sci. USA, 81: 6836–6840.

Zarrabeitia M. T. Rianchio J. A. Rodriguez-Valverde V. Farinas M. C. Gonzales-Macias J. , 1987. Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes Blut, 54: 343–349.